← Eichor
Study identifier: NCT06630702 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease

Condition: Parkinson Disease · Freezing of Gait · Spinal Cord Stimulation  ·  Sponsor: National Taiwan University Hospital

PhaseNA
Planned participants5
Who can joinAll sexes, 40 Years to 85 Years
Healthy volunteersNo

About this study

Spinal cord stimulation (SCS) has proven to be effective for pain that is unresponsive to medication. This technique involves an anesthesiologist or a neurosurgeon placing stimulation electrodes at the thoracic vertebrae to provide pain relief. Although SCS is not currently a standard treatment for patients with Parkinson's disease, recent studies have shown that Parkinson's patients who experience intolerable pain and undergo SCS treatment not only experience pain relief but also show improvements in gait and other Parkinson's symptoms. Therefore, the investigators aim to use temporary, minimally invasive SCS electrodes to help patients with nrFOG (non-responsive Freezing of Gait) improve their stability and reduce their risk of falls.

This description comes directly from the study's public registry record.

Talk to the study team

Kai-Hsiang Chen, M.D.  ·  +886-3-5326151  ·  stanleychen1230@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

National Taiwan University Hospital Hsin-Chu BranchHsinchu, Hsinchu City, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06630702